Zusammenfassung
Im Sinne der Anti-Doping-Konvention des Europarates (Bundesgestzblatt 451/1991) bedeutet (bedeuten):
-
a)
„Doping im Sport“ ist die Verabreichung oder die Anwendung pharmakologischer Dopingwirkstoffe oder Dopingmethoden an bzw. durch Sportler und Sportlerinnen.
-
b)
„Pharmakologische Dopingwirkstoffe oder Dopingmethoden“ werden von den betreffenden internationalen Sportorganisationen verboten und in Listen aufgeführt.
-
c)
„Sportler und Sportlerinnen“ sind die Personen, die regelmäßig an organisierten Sportaktivitäten teilnehmen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Audran M, Gareu R, Matecki S, Durand F, Chenard C, Sicart M, Marion B, Bressolle F (1989) Effects of erythropoietin administration in training athletes and possible detection in doping control. Med Sci Sports Exerc 639–645
Bhasin S, Storer T, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell T, Tricker R, Shirazi A,Casaburi R (1996) The effects of supraphysiological doses of testosterone on muscle size and strength in normal man. New Engl J Med 4 (335): 1–7
Chandler JV, Blair SN (1980) The effect of amphetamines on selected physiological compnents related to athletic success. Med Sci Sports Exerc 12: 65–69
Costill DL, Fink WJ (1978) Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 10: 155–158
Froehner M, Fischer R, Leike S, Hakenbe Go, Noack B, Wirth P(1999) Intratesticular leimomyosarcoma in a young man after high dose doping with oral-turinabol. Cancer 86 (8): 1571–1575
Gareau R, Audran M, Baynes RD, Flowers CH, Duvallet A, Semecal, Brisson GR (1996) Erythropoietin abuse in athletes. Nature 380: 113
Graham TE, Spriet LL (1991) Performance and metabolic responses to a high caffeine dose during pronlonged exercise. J Appl Physiol 71 (6) 2292–2298
Healy ML, Russel-Jones D (1997) Growth hormon and sport, potential benefits, and difficulties in detection. Brit J Sports Med 31: 267–268
Kamber M (2003) Information aus der Fachkommission für Dopingbekämpfung. Schw Z Sportmed 4: 192
Khaskin KB, Kleber HD (1989) Hooked on hormons? An anabolic steroid addiction hypothesis. JAMA 22: 3166–3170
Lasne F, De Ceaurriz J (2000) Recombinant erythropoeitin in urine. Nature 405
Magnavita N, Teofili L, Leone G (1996) Hodgkin’s lymphoma in a cyclist treated with growth hormone. Am J Hematol 52 (1): 65–66
Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugara C, Howe C., Martin DT, Trout GJ, Hahn, AG (2000) A novel method utilizing markers of altered erythropoiesis for the detection of recombinant erythropoietin abuse in athletes. Haematologica 85: 564–572
Phillips J, Bunnell T, Tricker R, Shirazi A,Casaburi R: The effects of supraphysiological doses of testosterone on muscle size and strength in normal man. New Engl J Med 335(1): 1–7
Riedl TH (2003) Doping 2004. ÖAZ 26
Tarnopolsky M (1994) Caffeine and endurance performance. J Sports Med 18 (2): 109–124
Wolfe R, Ferrando A, Sheffield-Moore M, Uraban R (2000) Testosteron and muscle protein metabolism. Mayo Clin Proc [Suppl] 75: 55–60
Weiterführende Literatur
Berendonk B (1991) Doping Dokumente, Von der Forschung zum Betrug. Springer, Berlin Heidelberg New York Tokyo
Clasing D, Donike M (1992) Doping, Verbotene Arzneimittel im Sport. Fischerverlag, Stuttgart Grundig P, Bachmann M (1994) Anabole Steroide
Kern J (2002) Das Dopingproblem. Maudrich Verlag, Wien
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Wien
About this chapter
Cite this chapter
Kern, J. (2004). II Doping. In: Pokan, R., Förster, H., Hofmann, P., Hörtnagl, H., Ledl-Kurkowski, E., Wonisch, M. (eds) Kompendium der Sportmedizin. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3781-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3781-9_17
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-21253-0
Online ISBN: 978-3-7091-3781-9
eBook Packages: Springer Book Archive